1.
Sussman G, Hebert J, Gulliver W, Lynde C, Yang WH, Chambenoit O, Deutsch G, DeTakacsy F, Rihakova L. Design and rational of the OPTIMA Study: Retreatment or Step-Up Therapy with Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU). J of Skin [Internet]. 2017Oct.27 [cited 2022Jun.30];1(3.1):s125. Available from: https://jofskin.org/index.php/skin/article/view/184